IL128531A0 - Method for treating heart failure - Google Patents
Method for treating heart failureInfo
- Publication number
- IL128531A0 IL128531A0 IL12853199A IL12853199A IL128531A0 IL 128531 A0 IL128531 A0 IL 128531A0 IL 12853199 A IL12853199 A IL 12853199A IL 12853199 A IL12853199 A IL 12853199A IL 128531 A0 IL128531 A0 IL 128531A0
- Authority
- IL
- Israel
- Prior art keywords
- heart failure
- treating heart
- treating
- failure
- heart
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7493498P | 1998-02-17 | 1998-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL128531A0 true IL128531A0 (en) | 2000-01-31 |
Family
ID=22122537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12853199A IL128531A0 (en) | 1998-02-17 | 1999-02-15 | Method for treating heart failure |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6043260A (hu) |
| EP (1) | EP0951906A1 (hu) |
| JP (1) | JPH11292766A (hu) |
| KR (1) | KR19990072616A (hu) |
| CN (1) | CN1231176A (hu) |
| AP (1) | AP9901464A0 (hu) |
| AR (1) | AR017723A1 (hu) |
| AU (1) | AU1732999A (hu) |
| BG (1) | BG103180A (hu) |
| BR (1) | BR9900653A (hu) |
| CA (1) | CA2262252C (hu) |
| EA (1) | EA199900124A3 (hu) |
| GT (1) | GT199900015A (hu) |
| HR (1) | HRP990054A2 (hu) |
| HU (1) | HUP9900386A3 (hu) |
| ID (1) | ID23218A (hu) |
| IL (1) | IL128531A0 (hu) |
| IS (1) | IS4975A (hu) |
| MA (1) | MA26608A1 (hu) |
| NO (1) | NO990722L (hu) |
| OA (1) | OA10976A (hu) |
| PA (1) | PA8467401A1 (hu) |
| PE (1) | PE20000266A1 (hu) |
| PL (1) | PL331507A1 (hu) |
| SG (1) | SG81261A1 (hu) |
| TN (1) | TNSN99024A1 (hu) |
| TR (1) | TR199900328A2 (hu) |
| ZA (1) | ZA991220B (hu) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7125880B1 (en) | 1995-06-06 | 2006-10-24 | Pfizer Inc. | Corticotropin releasing factor antagonists |
| US6956047B1 (en) | 1995-06-06 | 2005-10-18 | Pfizer Inc. | Corticotropin releasing factor antagonists |
| US6403599B1 (en) | 1995-11-08 | 2002-06-11 | Pfizer Inc | Corticotropin releasing factor antagonists |
| US6387894B1 (en) * | 1999-06-11 | 2002-05-14 | Pfizer Inc. | Use of CRF antagonists and renin-angiotensin system inhibitors |
| US6376242B1 (en) * | 1999-09-21 | 2002-04-23 | Emory University | Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents |
| IL150632A0 (en) * | 2000-01-18 | 2003-02-12 | Pfizer Prod Inc | Corticotropin releasing factor antagonists |
| GB0027410D0 (en) * | 2000-11-09 | 2000-12-27 | Pfizer Ltd | Mutual prodrug of amlodipine and atorvastatin |
| US6737430B2 (en) | 2000-11-09 | 2004-05-18 | Pfizer, Inc. | Mutual prodrug of amlodipine and atorvastatin |
| US6992087B2 (en) | 2001-11-21 | 2006-01-31 | Pfizer Inc | Substituted aryl 1,4-pyrazine derivatives |
| EP1476165A1 (en) | 2002-02-22 | 2004-11-17 | PHARMACIA & UPJOHN COMPANY | Substituted pyrimidinones and pyrimidinthiones |
| WO2003078435A1 (en) * | 2002-03-13 | 2003-09-25 | Pharmacia & Upjohn Company Llc | Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators |
| EP1499599A1 (en) * | 2002-04-26 | 2005-01-26 | Pharmacia & Upjohn Company LLC | Substituted pyrazine derivatives |
| WO2004024719A1 (en) * | 2002-09-12 | 2004-03-25 | Pharmacia & Upjohn Company Llc | Substituted 1,4-pyrazine derivatives |
| AR041470A1 (es) * | 2002-10-17 | 2005-05-18 | Upjohn Co | Compuestos de pirrolo (1,2 - b) piridazina y sus usos |
| EP1565454A1 (en) * | 2002-11-21 | 2005-08-24 | Pharmacia & Upjohn Company LLC | Pyrazine compounds as crf modulators |
| BRPI0409649A (pt) * | 2003-04-23 | 2006-04-25 | Pharmacia & Upjohn Co Llc | pirimidinonas e pirimidinotionas substituìdas como antagonistas de crf |
| WO2004099213A2 (en) * | 2003-05-07 | 2004-11-18 | Pharmacia & Upjohn Company Llc | Pyrrolo (1,2-b) pyridazine compounds and their use as crf-1 receptor antagonists |
| JP2006525987A (ja) * | 2003-05-09 | 2006-11-16 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 置換ピリミジン誘導体 |
| MXPA05012087A (es) * | 2003-05-09 | 2006-02-22 | Pharmacia & Upjohn Co Llc | Nuevas pirazinonas como antagonistas del receptor crf1. |
| WO2004099201A1 (en) * | 2003-05-09 | 2004-11-18 | Pharmacia & Upjohn Company Llc | Compounds as crf1 receptor antagonists |
| WO2005089639A2 (en) * | 2004-03-16 | 2005-09-29 | Talarico M D Matthew T | Method for vascular dysregulation |
| US20060211710A1 (en) * | 2005-03-17 | 2006-09-21 | Pfizer Inc | Substituted aryl 1,4-pyrazine derivatives |
| US8338441B2 (en) * | 2009-05-15 | 2012-12-25 | Gilead Sciences, Inc. | Inhibitors of human immunodeficiency virus replication |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW574214B (en) * | 1994-06-08 | 2004-02-01 | Pfizer | Corticotropin releasing factor antagonists |
| US6403599B1 (en) * | 1995-11-08 | 2002-06-11 | Pfizer Inc | Corticotropin releasing factor antagonists |
| EP0795327A1 (en) * | 1996-03-13 | 1997-09-17 | Pfizer Inc. | Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin |
-
1999
- 1999-01-18 PA PA19998467401A patent/PA8467401A1/es unknown
- 1999-02-02 GT GT199900015A patent/GT199900015A/es unknown
- 1999-02-10 SG SG9900526A patent/SG81261A1/en unknown
- 1999-02-10 US US09/248,073 patent/US6043260A/en not_active Expired - Fee Related
- 1999-02-11 CN CN99102122A patent/CN1231176A/zh active Pending
- 1999-02-11 IS IS4975A patent/IS4975A/is unknown
- 1999-02-11 AP APAP/P/1999/001464A patent/AP9901464A0/en unknown
- 1999-02-11 EP EP99301006A patent/EP0951906A1/en not_active Withdrawn
- 1999-02-12 BR BR9900653-7A patent/BR9900653A/pt not_active Application Discontinuation
- 1999-02-12 KR KR1019990004934A patent/KR19990072616A/ko not_active Application Discontinuation
- 1999-02-12 PE PE1999000127A patent/PE20000266A1/es not_active Application Discontinuation
- 1999-02-15 ID IDP990113D patent/ID23218A/id unknown
- 1999-02-15 CA CA002262252A patent/CA2262252C/en not_active Expired - Fee Related
- 1999-02-15 IL IL12853199A patent/IL128531A0/xx unknown
- 1999-02-16 ZA ZA9901220A patent/ZA991220B/xx unknown
- 1999-02-16 NO NO990722A patent/NO990722L/no unknown
- 1999-02-16 TN TNTNSN99024A patent/TNSN99024A1/fr unknown
- 1999-02-16 AR ARP990100619A patent/AR017723A1/es unknown
- 1999-02-16 TR TR1999/00328A patent/TR199900328A2/xx unknown
- 1999-02-16 AU AU17329/99A patent/AU1732999A/en not_active Abandoned
- 1999-02-16 BG BG103180A patent/BG103180A/bg unknown
- 1999-02-16 EA EA199900124A patent/EA199900124A3/ru unknown
- 1999-02-16 OA OA9900034A patent/OA10976A/en unknown
- 1999-02-16 MA MA25465A patent/MA26608A1/fr unknown
- 1999-02-16 JP JP11037464A patent/JPH11292766A/ja active Pending
- 1999-02-16 HU HU9900386A patent/HUP9900386A3/hu unknown
- 1999-02-17 PL PL99331507A patent/PL331507A1/xx unknown
- 1999-02-17 HR HR60/074,934A patent/HRP990054A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA991220B (en) | 2000-08-16 |
| ID23218A (id) | 2000-03-30 |
| MA26608A1 (fr) | 2004-12-20 |
| NO990722D0 (no) | 1999-02-16 |
| HU9900386D0 (en) | 1999-04-28 |
| NO990722L (no) | 1999-08-18 |
| SG81261A1 (en) | 2001-06-19 |
| US6043260A (en) | 2000-03-28 |
| BG103180A (bg) | 1999-09-30 |
| HUP9900386A2 (hu) | 1999-11-29 |
| KR19990072616A (ko) | 1999-09-27 |
| PE20000266A1 (es) | 2000-04-07 |
| GT199900015A (es) | 2000-07-26 |
| CA2262252C (en) | 2006-01-10 |
| EA199900124A2 (ru) | 1999-08-26 |
| HRP990054A2 (en) | 2000-02-29 |
| OA10976A (en) | 2001-11-05 |
| PA8467401A1 (es) | 2000-09-29 |
| AU1732999A (en) | 1999-09-02 |
| TR199900328A2 (xx) | 1999-10-21 |
| BR9900653A (pt) | 2000-10-17 |
| HUP9900386A3 (en) | 1999-12-28 |
| PL331507A1 (en) | 1999-08-30 |
| AR017723A1 (es) | 2001-09-12 |
| CN1231176A (zh) | 1999-10-13 |
| JPH11292766A (ja) | 1999-10-26 |
| AP9901464A0 (en) | 1999-03-31 |
| EA199900124A3 (ru) | 1999-12-29 |
| IS4975A (is) | 1999-08-18 |
| TNSN99024A1 (fr) | 2005-11-10 |
| CA2262252A1 (en) | 1999-08-17 |
| EP0951906A1 (en) | 1999-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL128531A0 (en) | Method for treating heart failure | |
| EP1180040A4 (en) | METHODS OF TREATING CONGESTIVE HEART FAILURE | |
| EP0792371A4 (en) | COMBINED ACNE TREATMENT PROCESS | |
| SG50018A1 (en) | Method for developing treatment | |
| HK1010220A1 (en) | Method for surface treatment. | |
| GB2359314B (en) | Technique for treating wells | |
| GB9605828D0 (en) | Treatment method | |
| IL130531A0 (en) | Method for treating glaucoma | |
| EP1009403A4 (en) | METHOD FOR TREATING SCHIZOPHRENIA | |
| PL341667A1 (en) | Method of treating cooped | |
| IL125762A0 (en) | Method for treating heart failure | |
| GB9714841D0 (en) | Treatment method | |
| EP0786999A4 (en) | COMBINED ACNE TREATMENT PROCESS | |
| ZA974978B (en) | Formulation and method for treating congestive heart failure | |
| ZA975264B (en) | Method for treating congestive heart failure. | |
| ZA200007396B (en) | Method of treatment. | |
| HU9903735D0 (en) | Method for treating congestive heart failure | |
| ZA988745B (en) | Compounds for treating heart failure | |
| EA199900063A3 (ru) | Способ лечения организма пациента | |
| GB9703102D0 (en) | Treatment method | |
| GB9822681D0 (en) | Method of treatment | |
| GB9600610D0 (en) | Treatment method | |
| GB9614742D0 (en) | Treatment method | |
| GB9614741D0 (en) | Treatment method | |
| GB9614743D0 (en) | Treatment method |